By ALEX BERENSON
Published: January 15, 2008
A clinical trial of Zetia, a widely used cholesterol drug, has raised questions about its effectiveness and the behavior of pharmaceutical companies that conducted the study.
http://www.nytimes.com/2008/01/15/business/15drug.html?ex=1358226000&en=dba4b9b6fb66e970&ei=5124&partner=permalink&exprod=permalink
Sunday, January 20, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment